The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis

F Matcham, L Rayner, S Steer, M Hotopf - Rheumatology, 2013 - academic.oup.com
Objective. There is substantial uncertainty regarding the prevalence of depression in RA.
We conducted a systematic review aiming to describe the prevalence of depression in RA. …

[HTML][HTML] Using smartphones and wearable devices to monitor behavioral changes during COVID-19

…, P Conde, C Stewart, N Cummins, F Matcham… - Journal of medical …, 2020 - jmir.org
Background In the absence of a vaccine or effective treatment for COVID-19, countries have
adopted nonpharmaceutical interventions (NPIs) such as social distancing and full lockdown…

Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of a randomized …

F Matcham, S Norton, DL Scott, S Steer… - Rheumatology, 2016 - academic.oup.com
Objective. The aim of this analysis is to examine the longitudinal impact of symptoms of
depression/anxiety on treatment response, long-term disease activity and physical disability in RA…

[HTML][HTML] The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis

F Matcham, IC Scott, L Rayner, M Hotopf… - Seminars in arthritis and …, 2014 - Elsevier
Objective The assessment of health-related quality-of-life (HRQoL) in rheumatoid arthritis (RA)
is becoming increasingly common in both research and clinical practice. One of the most …

[HTML][HTML] Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol

F Matcham, C Barattieri di San Pietro, V Bulgari… - BMC psychiatry, 2019 - Springer
Background There is a growing body of literature highlighting the role that wearable and
mobile remote measurement technology (RMT) can play in measuring symptoms of major …

Antidepressants for the treatment of depression in people with cancer

G Ostuzzi, F Matcham, S Dauchy… - Cochrane Database …, 2018 - cochranelibrary.com
Background Major depression and other depressive conditions are common in people with
cancer. These conditions are not easily detectable in clinical practice, due to the overlap …

[HTML][HTML] Barriers to and facilitators of engagement with remote measurement technology for managing health: systematic review and content analysis of findings

S Simblett, B Greer, F Matcham, H Curtis… - Journal of medical …, 2018 - jmir.org
Background Remote measurement technology refers to the use of mobile health technology
to track and measure change in health status in real time as part of a person’s everyday life. …

[HTML][HTML] Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs

L Rayner, M Hotopf, H Petkova, F Matcham, A Simpson… - Pain, 2016 - journals.lww.com
1. Background Chronic pain and depression are each prevalent and often co-occur. 5
Although the underlying mechanism of the interaction between pain and depression is not fully …

[HTML][HTML] Digital health tools for the passive monitoring of depression: a systematic review of methods

…, D Leightley, E Oprea, G Lavelle, F Matcham… - NPJ digital …, 2022 - nature.com
The use of digital tools to measure physiological and behavioural variables of potential
relevance to mental health is a growing field sitting at the intersection between computer science, …

Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis

SK Simblett, E Bruno, S Siddi, F Matcham, L Giuliano… - Epilepsy & Behavior, 2019 - Elsevier
Background Innovative uses of mobile health (mHealth) technology for real-time measurement
and management of epilepsy may improve the care provided to patients. For instance, …